Zobrazeno 1 - 10
of 272
pro vyhledávání: '"Yuka Yasuda"'
Autor:
Tzuyao Lo, Itaru Kushima, Hiroki Kimura, Branko Aleksic, Takashi Okada, Hidekazu Kato, Toshiya Inada, Yoshihiro Nawa, Youta Torii, Maeri Yamamoto, Ryo Kimura, Yasuko Funabiki, Hirotaka Kosaka, Shusuke Numata, Kiyoto Kasai, Tsukasa Sasaki, Shigeru Yokoyama, Toshio Munesue, Ryota Hashimoto, Yuka Yasuda, Michiko Fujimoto, Masahide Usami, Masanari Itokawa, Makoto Arai, Kazutaka Ohi, Toshiyuki Someya, Yuichiro Watanabe, Jun Egawa, Tsutomu Takahashi, Michio Suzuki, Hidenori Yamasue, Nakao Iwata, Masashi Ikeda, Norio Ozaki
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 42-50 (2024)
Abstract Aim The present study aimed to examine the association between copy number variations (CNVs) in parkin (PRKN) and schizophrenia (SCZ) and autism spectrum disorder (ASD) in a large case–control sample. Method Array comparative genomic hybri
Externí odkaz:
https://doaj.org/article/7c5247e49f9446b48f67640ae93b6ce0
Autor:
Ryuichi Yamazaki, Junya Matsumoto, Satsuki Ito, Kiyotaka Nemoto, Masaki Fukunaga, Naoki Hashimoto, Fumitoshi Kodaka, Harumasa Takano, Naomi Hasegawa, Yuka Yasuda, Michiko Fujimoto, Hidenaga Yamamori, Yoshiyuki Watanabe, Kenichiro Miura, Ryota Hashimoto
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 206-215 (2024)
Abstract Establishing a brain biomarker for schizophrenia is strongly desirable not only to support diagnosis by psychiatrists but also to help track the progressive changes in the brain over the course of the illness. A brain morphological signature
Externí odkaz:
https://doaj.org/article/f63d409e9c7f4e6e822e230c480c1440
Autor:
Masatoshi Yoshida, Kenichiro Miura, Michiko Fujimoto, Hidenaga Yamamori, Yuka Yasuda, Masao Iwase, Ryota Hashimoto
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Abnormalities in visual exploration affect the daily lives of patients with schizophrenia. For example, scanpath length during free-viewing is shorter in schizophrenia. However, its origin and its relevance to symptoms are unknown. Here we i
Externí odkaz:
https://doaj.org/article/0e1bcad9c2384d30b12d332195e9ace8
Autor:
Kentaro Morita, Kenichiro Miura, Atsuhito Toyomaki, Manabu Makinodan, Kazutaka Ohi, Naoki Hashimoto, Yuka Yasuda, Takako Mitsudo, Fumihiro Higuchi, Shusuke Numata, Akiko Yamada, Yohei Aoki, Hiromitsu Honda, Ryo Mizui, Masato Honda, Daisuke Fujikane, Junya Matsumoto, Naomi Hasegawa, Satsuki Ito, Hisashi Akiyama, Toshiaki Onitsuka, Yoshihiro Satomura, Kiyoto Kasai, Ryota Hashimoto
Publikováno v:
JMIR Mental Health, Vol 11, p e56668 (2024)
BackgroundSchizophrenia is a complex mental disorder characterized by significant cognitive and neurobiological alterations. Impairments in cognitive function and eye movement have been known to be promising biomarkers for schizophrenia. However, cog
Externí odkaz:
https://doaj.org/article/320b7793cec64719bb12220886cb4909
Autor:
Satsuki Ito, Kazutaka Ohi, Yuka Yasuda, Michiko Fujimoto, Hidenaga Yamamori, Junya Matsumoto, Kentaro Fukumoto, Fumitoshi Kodaka, Naomi Hasegawa, Keiichiro Ishimaru, Kenichiro Miura, Norio Yasui-Furukori, Ryota Hashimoto
Publikováno v:
Schizophrenia, Vol 9, Iss 1, Pp 1-6 (2023)
Abstract Schizophrenia is a psychiatric disorder that is associated with various social dysfunctions, including shorter work hours. To measure the degree to which psychiatrists adhere to guidelines for pharmacological therapy of schizophrenia, we rec
Externí odkaz:
https://doaj.org/article/fff047ed39db4d5eb966889c21b4f05c
Autor:
Yoshie Sakai, Satsuki Ito, Junya Matsumoto, Yuka Yasuda, Hidenaga Yamamori, Michiko Fujimoto, Naomi Hasegawa, Keiichiro Ishimaru, Kenichiro Miura, Ryota Hashimoto
Publikováno v:
Neuropsychopharmacology Reports, Vol 43, Iss 3, Pp 373-381 (2023)
Abstract Aims Schizophrenia is a psychiatric disorder presenting a lack of insight. Although insight changes over time, longitudinal studies of insight in schizophrenia are scarce. Furthermore, most previous studies on insight and intelligence have n
Externí odkaz:
https://doaj.org/article/5412e07e4e504cb39bd0278c2288d0fc
Autor:
Kentaro Fukumoto, Fumitoshi Kodaka, Naomi Hasegawa, Hiroyuki Muraoka, Hikaru Hori, Kayo Ichihashi, Yuka Yasuda, Hitoshi Iida, Kazutaka Ohi, Shinichiro Ochi, Kenta Ide, Naoki Hashimoto, Masahide Usami, Toshinori Nakamura, Hiroshi Komatsu, Tsuyoshi Okada, Tatsuya Nagasawa, Ryuji Furihata, Kiyokazu Atake, Mikio Kido, Saya Kikuchi, Hirotaka Yamagata, Taishiro Kishimoto, Manabu Makinodan, Tadasu Horai, Masahiro Takeshima, Chika Kubota, Takeshi Asami, Eiichi Katsumoto, Akitoyo Hishimoto, Toshiaki Onitsuka, Junya Matsumoto, Kenichiro Miura, Hisashi Yamada, Norio Yasui‐Furukori, Koichiro Watanabe, Ken Inada, Kotaro Otsuka, Ryota Hashimoto
Publikováno v:
Neuropsychopharmacology Reports, Vol 43, Iss 1, Pp 33-39 (2023)
Abstract Aim Treatment guidelines are designed to assist patients and health care providers and are used as tools for making treatment decisions in clinical situations. The treatment guidelines of the Japanese Society of Mood Disorders establish trea
Externí odkaz:
https://doaj.org/article/77c5010860b649c9b9cab36a727c3c74
Autor:
Ken Inada, Kentaro Fukumoto, Naomi Hasegawa, Yuka Yasuda, Hisashi Yamada, Hikaru Hori, Kayo Ichihashi, Hitoshi Iida, Kazutaka Ohi, Hiroyuki Muraoka, Fumitoshi Kodaka, Kenta Ide, Naoki Hashimoto, Jun‐ichi Iga, Kazuyoshi Ogasawara, Kiyokazu Atake, Yoshikazu Takaesu, Tatsuya Nagasawa, Hiroshi Komatsu, Tsuyoshi Okada, Ryuji Furihata, Mikio Kido, Saya Kikuchi, Chika Kubota, Manabu Makinodan, Shinichiro Ochi, Masahiro Takeshima, Hirotaka Yamagata, Junya Matsumoto, Kenichiro Miura, Masahide Usami, Taishiro Kishimoto, Toshiaki Onitsuka, Eiichi Katsumoto, Akitoyo Hishimoto, Shusuke Numata, Norio Yasui‐Furukori, Koichiro Watanabe, Ryota Hashimoto
Publikováno v:
Neuropsychopharmacology Reports, Vol 42, Iss 4, Pp 502-509 (2022)
Abstract Aims The Guidelines for the Pharmacotherapy of Schizophrenia were established to improve the quality of medical care, and the EGUIDE project was conducted to train clinicians on guideline usage. A quality indicator (QI) was established to me
Externí odkaz:
https://doaj.org/article/71db657687454769b1c8f814ad0c4bbd
Autor:
Yoshitaka Kyou, Norio Yasui-Furukori, Naomi Hasegawa, Kenta Ide, Kayo Ichihashi, Naoki Hashimoto, Hikaru Hori, Yoshihito Shimizu, Yayoi Imamura, Hiroyuki Muraoka, Hitoshi Iida, Kazutaka Ohi, Yuka Yasuda, Kazuyoshi Ogasawara, Shusuke Numata, Jun-ichi Iga, Takashi Tsuboi, Shinichiro Ochi, Fumitoshi Kodaka, Ryuji Furihata, Toshiaki Onitsuka, Manabu Makinodan, Hiroshi Komatsu, Masahiro Takeshima, Chika Kubota, Akitoyo Hishimoto, Kiyokazu Atake, Hirotaka Yamagata, Mikio Kido, Tatsuya Nagasawa, Masahide Usami, Taishiro Kishimoto, Saya Kikuchi, Junya Matsumoto, Kenichiro Miura, Hisashi Yamada, Koichiro Watanabe, Ken Inada, Ryota Hahimoto
Publikováno v:
Annals of General Psychiatry, Vol 21, Iss 1, Pp 1-8 (2022)
Abstract Background Several guidelines recommend monotherapy in pharmacotherapy for schizophrenia and major depressive disorder. The content of regular prescriptions has been reported in several studies, but not enough research has been conducted on
Externí odkaz:
https://doaj.org/article/73ffe19110cd4489b776e7d60d078acf
Autor:
Yuria Demizu, Junya Matsumoto, Yuka Yasuda, Satsuki Ito, Kenichiro Miura, Hidenaga Yamamori, Michiko Fujimoto, Naomi Hasegawa, Keiichiro Ishimaru, Ryota Hashimoto
Publikováno v:
Neuropsychopharmacology Reports, Vol 42, Iss 2, Pp 226-229 (2022)
Abstract Aim Social functioning is influenced by various factors. Autistic traits could be one of the factors that affect social functioning. Methods In the present study, the relationship between autistic traits and social functioning among 755 heal
Externí odkaz:
https://doaj.org/article/b16290ecd9444154880449baedcf11d0